Novus Therapeutics, Inc.
Irvine, United States (US) · Health and Medical
Do your work at Novus Therapeutics, Inc.?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
#clinical development
#biotechnology
#autoimmune diseases
#transplant
#als
#renal transplant
#islet cell transplant
#lupus nephritis
#type 1 diabetes
Overview
We are dedicated to ‘One Transplant For Life’ to significantly improve both the longevity of the organ and the overall health and quality of life for transplant recipients so that a donor’s greatest gift will keep on giving.
Our lead compound, tegoprubart, an anti-CD40L antibody, offers a potentially transformative approach to managing immune responses in transplant patients, representing a significant advancement over existing treatment options. We are currently evaluating its potential in kidney, liver, and xenotransplantation.
Novus Therapeutics is committed to advancing the field of transplantation and improving patient outcomes through rigorous clinical development and scientific innovation.
Contact Details
Irvine, United States (US), 19900 MacArthur Blvd, Suite 550
Founded
2017
Company Type
Public Limited Company
Employees
10-20
Categories
Keywords
#clinical development
#biotechnology
#autoimmune diseases
#transplant
#als
#renal transplant
#islet cell transplant
#lupus nephritis
#type 1 diabetes
Companies teams usually look at after Novus Therapeutics, Inc.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.